½ÃÀ庸°í¼­
»óǰÄÚµå
1611530

¾ÈÀú Ä«¸Þ¶ó ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Fundus Cameras Market Size, Share & Trends Analysis Report By Product, By End Use (Hospitals, Ophthalmology Clinics, Ophthalmic & Optometrist Offices), By Region (North America, Europe, Latin America, MEA), And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 170 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¾ÈÀú Ä«¸Þ¶ó ½ÃÀå ¼ºÀå°ú µ¿Çâ:

Grand View Research, Inc.ÀÇ »õ·Î¿î º¸°í¼­¿¡ µû¸£¸é, ¼¼°è ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå ±Ô¸ð´Â 2025-2030³â ¿¬Æò±Õ 6.4%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â¿¡´Â 5¾ï 3,500¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ³ëÀÎ Àα¸ÀÇ Áõ°¡, ´ç´¢º´ ¹× °íÇ÷¾Ð°ú °°Àº ¸¸¼ºÁúȯÀÇ Áõ°¡·Î ÀÎÇØ ¸Á¸· ÁúȯÀÇ ¹ßº´·üÀÌ ´õ¿í Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¿¹¸¦ µé¾î, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ 2016³â º¸°í¼­¿¡ µû¸£¸é 2014³â Àü ¼¼°è 4¾ï 2,200¸¸ ¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖ´Ù°í ÇÕ´Ï´Ù. ¶ÇÇÑ AMD, ´ç´¢¸Á¸·º´Áõ, ³ì³»Àå µî ºñÀü¿°¼º ÁúȯÀÇ Áõ°¡´Â Àü ¼¼°è ½Ç¸í Àα¸ÀÇ Áõ°¡¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ÀÌ·¯ÇÑ ¾ÈÁúȯÀÇ ¿µÇâÀ» ¾ïÁ¦Çϱâ À§ÇØ ¾ÈÀú Ä«¸Þ¶ó´Â Áø´Ü ¸ñÀûÀ¸·Î ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÇÏÀ̺긮µå, ÈÞ´ë¿ë, ÈÞ´ë¿ë, ÇÚµåÇïµå, µ¶¸³Çü µî ´Ù¾çÇÑ À¯ÇüÀÇ ¾ÈÀú Ä«¸Þ¶ó¸¦ »ç¿ëÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ç´¢¸Á¸·º´Áõ(DR), ¹Ì¼÷¾Æ ¸Á¸·Áõ(ROP), ¿¬·É°ü·Ã Ȳ¹Ýº¯¼º(AMD)Àº ¸Á¸· ½Ç¸íÀÇ ÁÖ¿ä ¿øÀÎÀ̸ç, Áõ°¡ Ãß¼¼¿¡ ÀÖ½À´Ï´Ù. Æò±Õ ¼ö¸íÀÇ Áõ°¡·Î ÀÎÇØ ³ëÀÎ Àα¸°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, ¾ÕÀ¸·Îµµ ´õ¿í Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¹Ì±¹ Àα¸Á¶»ç±¹ÀÇ ±¹Á¦ µ¥ÀÌÅͺ£À̽º¿¡ µû¸£¸é 2015³â Àü ¼¼°è ³ëÀÎ Àα¸´Â 6¾ï 1,710¸¸ ¸í¿¡ À°¹ÚÇϸç, 2030³â¿¡´Â 9¾ï 9,870¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È Àüü ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¶ÇÇÑ, ¾ÈÀú Ä«¸Þ¶ó¿¡ ´ëÇÑ Á¤ºÎÀÇ Áö¿øÀûÀÎ ±ÔÁ¦´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹°ú ÀϺ»ÀÇ ±ÔÁ¦ ±â°üÀº ¾ÈÀú Ä«¸Þ¶ó¸¦ 4³â¸¶´Ù ±³Ã¼ÇØ¾ß ÇÑ´Ù°í ¸í½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¤ºÎ ±â°üÀÇ ³ë·ÂÀº 4³â¸¶´Ù ¾ÈÀú »çÁøÀÇ »õ·Î¿î ¹ßÀüÀ» ½ÃÇàÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, À̸¦ ÅëÇØ ¾ÈÁúȯÀÇ Áø´ÜÀ» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª OCT¿Í °°Àº ¾È°ú Áúȯ Áø´ÜÀ» À§ÇÑ ´Ù¸¥ ÷´Ü ±â¼úÀÌ Á¸ÀçÇϱ⠶§¹®¿¡ ¾ÈÀú Ä«¸Þ¶óÀÇ Ã¤ÅÃÀ» ¹æÇØÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â ¿¹Ãø ±â°£ µ¿¾È Àüü ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù.

¾ÈÀú Ä«¸Þ¶ó ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • ¹«»êµ¿ Ä«¸Þ¶ó ºÎ¹®Àº 2024³â 49.4%ÀÇ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ÀÌ´Â Àü¹®Àǰ¡ ¸Á¸·ÀÇ ÇØºÎÇÐÀû ±¸Á¶¸¦ ÀÚ¼¼È÷ º¼ ¼ö ÀÖ¾î ¾È°ú ÁúȯÀÇ Áø´Ü ¹× °ü¸®¸¦ °­È­ÇÒ ¼ö Àֱ⠶§¹®ÀÔ´Ï´Ù.
  • ¹«»êµ¿ Ä«¸Þ¶ó¿Í »êµ¿ Ä«¸Þ¶ó´Â ´Ù½Ã Ź»óÇü°ú ÈÞ´ë¿ëÀ¸·Î ¼¼ºÐÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ź»ó¿ëÀº ÇÚµåÇïµåº¸´Ù »ó¿ëÈ­µÈ Á¦Ç° ¼ö°¡ ¸¹°í È­ÁúÀÌ ÁÁ±â ¶§¹®¿¡ 2024³â ½ÃÀå¿¡¼­´Â Ź»ó¿ëÀÌ ¿ìÀ§¸¦ Á¡ÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.
  • ºÏ¹Ì´Â 2024³â ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå¿¡¼­ 37.4%ÀÇ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÏ¸ç µ¶º¸ÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ Áö¿ªÀÇ ¼ºÀå¿¡ ±â¿©ÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ³ëÀÎ Àα¸ÀÇ Áõ°¡¿Í ÀÌ ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀÌ ÀÖ½À´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾ÈÀú Ä«¸Þ¶ó ½ÃÀåÀº 2025-2030³â »çÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× ÀÌÀ¯´Â ÁÖ¿ä ±â¾÷ÀÇ ÇöÁö ÁøÃâ, Àü¹®°¡ ¼­ºñ½ºÀÇ °¡¿ë¼º, ÀÇ·á °ü±¤ÀÇ ¼ºÀå¿¡ ±âÀÎÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óºÎ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® : Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : Á¦Ç° º¯µ¿ ºÐ¼®
  • ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : Á¦Ç° Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
  • »êµ¿ ¾ÈÀú Ä«¸Þ¶ó
    • Ź»óÇü
    • ÇÚµåÇïµåÇü
  • ºñ»êµ¿ ¾ÈÀú Ä«¸Þ¶ó
    • Ź»óÇü
    • ÇÚµåÇïµåÇü
  • ÇÏÀ̺긮µå ¾ÈÀú Ä«¸Þ¶ó
  • ROP ¾ÈÀú Ä«¸Þ¶ó

Á¦5Àå ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : ÃÖÁ¾ ¿ëµµ º¯µ¿ ºÐ¼®
  • ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : ÃÖÁ¾ ¿ëµµ Àü¸Á
  • 2018-2030³â ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø°ú µ¿Ç⠺м®
  • º´¿ø
  • ¾È°ú Ŭ¸®´Ð
  • ¾È°ú¡¤°Ë¾È½Ç

Á¦6Àå ¾ÈÀú Ä«¸Þ¶ó ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®(2024³â¡¤2030³â)
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ¼¼°èÀÇ Áö¿ª ½ÃÀå ÇöȲ
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®(2018-2030³â)
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • ½º¿þµ§
    • µ§¸¶Å©
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • Çѱ¹
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦7Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ ±â¾÷ÀÇ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ±â¾÷/°æÀï ºÐ·ù
    • À̳뺣ÀÌÅÍ
  • º¥´õ »óȲ
    • ÁÖ¿ä ÆÇ¸Å´ë¸®Á¡¡¤Ã¤³Î ÆÄÆ®³Ê ¸®½ºÆ®
    • ÁÖ¿ä °í°´
    • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À² ºÐ¼® : 2024³â
    • Carl Zeiss Meditec, Inc.
    • Kowa Company Ltd.
    • Optomed Oy(Ltd.)
    • Optovue, Incorporated
    • CenterVue SpA
    • NIDEK Co., Ltd.
    • Topcon Medical Systems, Inc.
    • Clarity Medical Systems, Inc.
    • Canon, Inc.
ksm 25.01.06

Fundus Cameras Market Growth & Trends:

The global fundus cameras market size is expected to reach USD 535.0 million by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising geriatric population and growing occurrences of chronic disorders such as diabetes and hypertension further increase the incidence of retinal disorders.

For instance, according to the WHO 2016 report, globally, in 2014, 422.0 million people had diabetes. Additionally, increasing non-communicable diseases such as AMD, diabetic retinopathy, and glaucoma is contributing to the growing blind population globally. Therefore, to control the impact of these eye diseases, the fundus camera is widely used for diagnosis purposes. Availability of different types of fundus cameras such as hybrid, portable, handheld, and standalone is expected to propel the market growth during the forecast period.

Diabetic Retinopathy (DR), Retinopathy of Prematurity (ROP), and Age-Related Macular Degeneration (AMD) are major and increasing causes of retinal blindness. An increase in life expectancy has led to a rise in the geriatric population, which would further continue to rise in the future. According to the U.S. Census Bureau, international database, the global geriatric population was nearly 617.1 million in 2015 and is anticipated to reach 998.7 by 2030. This, in turn, is expected to drive the overall market growth during the forecast period.

In addition, supportive government regulations for fundus cameras are expected to fuel the market growth during the forecast period. For instance, regulatory agencies in the U.S. and Japan stated that the cameras should be replaced every 4 years. This initiative by the agencies will help in implementing new advancements in fundus photography every 4 years, thereby, enhancing the diagnosis of eye diseases. However, the presence of other advanced technologies such as OCT for the diagnosis of eye problems is expected to hinder the adoption of fundus cameras and may impact the overall market growth during the forecast period.

Fundus Cameras Market Report Highlights:

  • The non-mydriatic cameras segment dominated the market and accounted for the largest market share of 49.4% in 2024 due to increased demand, as it enables the practitioner to view the retinal anatomy in detail and provides enhanced diagnosis and management of eye diseases
  • Non-mydriatic and mydriatic camera can be further sub-segmented into tabletop and handheld. The tabletop segment dominated the market in 2024 because of the availability of a higher number of commercialized products and the ability to produce a better image quality than handheld products
  • North America dominated the fundus cameras market and accounted for the largest revenue share of 37.4% in 2024.Major factors contributing to the growth of this region include the increasing geriatric population and technical advances in the field.
  • The Asia Pacific fundus cameras market is expected to grow fastest from 2025 to 2030, because of the local presence of key players, the availability of expert services, and, growing medical tourism.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Fundus Cameras Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of eye diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing geriatric population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of advanced fundus cameras
      • 3.2.2.2. Lack of skilled professionals
  • 3.3. Fundus Cameras Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Fundus Cameras Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Fundus Cameras Market: Product Movement Analysis
  • 4.3. Fundus Cameras Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Mydriatic Fundus Cameras
    • 4.5.1. Mydriatic Fundus Cameras Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Tabletop
      • 4.5.2.1. Tabletop Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Handheld
      • 4.5.3.1. Handheld Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Non- Mydriatic Fundus Cameras
    • 4.6.1. Non- Mydriatic Fundus Cameras Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Tabletop
      • 4.6.2.1. Tabletop Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Handheld
      • 4.6.3.1. Handheld Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Hybrid Fundus Cameras
    • 4.7.1. Hybrid Fundus Cameras Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. ROP Fundus Cameras
    • 4.8.1. ROP Fundus Cameras Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Fundus Cameras Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Fundus Cameras Market: End Use Movement Analysis
  • 5.3. Fundus Cameras Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Ophthalmology Clinics
    • 5.6.1. Ophthalmology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Ophthalmic & Optometrist Offices
    • 5.7.1. Ophthalmic & Optometrist Offices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Fundus Cameras Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.10. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.11. Company/Competition Categorization
    • 1.11.1. Innovators
  • 7.12. Vendor Landscape
    • 7.12.1. List of key distributors and channel partners
    • 7.12.2. Key customers
    • 7.12.3. Key company market share analysis, 2024
    • 7.12.4. Carl Zeiss Meditec, Inc.
      • 7.12.4.1. Company overview
      • 7.12.4.2. Financial performance
      • 7.12.4.3. Product benchmarking
      • 7.12.4.4. Strategic initiatives
    • 7.12.5. Kowa Company Ltd.
      • 7.12.5.1. Company overview
      • 7.12.5.2. Financial performance
      • 7.12.5.3. Product benchmarking
      • 7.12.5.4. Strategic initiatives
    • 7.12.6. Optomed Oy (Ltd.)
      • 7.12.6.1. Company overview
      • 7.12.6.2. Financial performance
      • 7.12.6.3. Product benchmarking
      • 7.12.6.4. Strategic initiatives
    • 7.12.7. Optovue, Incorporated
      • 7.12.7.1. Company overview
      • 7.12.7.2. Financial performance
      • 7.12.7.3. Product benchmarking
      • 7.12.7.4. Strategic initiatives
    • 7.12.8. CenterVue SpA
      • 7.12.8.1. Company overview
      • 7.12.8.2. Financial performance
      • 7.12.8.3. Product benchmarking
      • 7.12.8.4. Strategic initiatives
    • 7.12.9. NIDEK Co., Ltd.
      • 7.12.9.1. Company overview
      • 7.12.9.2. Financial performance
      • 7.12.9.3. Product benchmarking
      • 7.12.9.4. Strategic initiatives
    • 7.12.10. Topcon Medical Systems, Inc.
      • 7.12.10.1. Company overview
      • 7.12.10.2. Financial performance
      • 7.12.10.3. Product benchmarking
      • 7.12.10.4. Strategic initiatives
    • 7.12.11. Clarity Medical Systems, Inc.
      • 7.12.11.1. Company overview
      • 7.12.11.2. Financial performance
      • 7.12.11.3. Product benchmarking
      • 7.12.11.4. Strategic initiatives
    • 7.12.12. Canon, Inc.
      • 7.12.12.1. Company overview
      • 7.12.12.2. Financial performance
      • 7.12.12.3. Product benchmarking
      • 7.12.12.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦